Effects of urapidil on pulmonary hypertension and blood gas in rheumatic heart disease

JIANG Yingjiu; et al

doi:10.13406/j.cnki.cyxb.2003.02.033

您当前的位置：

首页 >

文章列表页 >

Effects of urapidil on pulmonary hypertension and blood gas in rheumatic heart disease

更新时间：2024-01-17

- Effects of urapidil on pulmonary hypertension and blood gas in rheumatic heart disease
- Journal of Chongqing Medical University Issue 2, Pages: 222-224(2003)
- 作者机构：
  
  1. 重庆医科大学临床学院胸心外科
  2. 重庆医科大学临床学院胸心外科,重庆,400016
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.2003.02.033
  CLC： R541.2
- Published：2003，
扫描看全文
[1]蒋迎九,李朝先,向小勇,杨双强,李强,汪斌,黄阳礼.乌拉地尔对风心病肺动脉高压及血气的影响[J].重庆医科大学学报,2003(02):222-224.

JIANG Yingjiu, et al. Effects of urapidil on pulmonary hypertension and blood gas in rheumatic heart disease. [J]. Journal of Chongqing Medical University (2):222-224(2003)
[1]蒋迎九,李朝先,向小勇,杨双强,李强,汪斌,黄阳礼.乌拉地尔对风心病肺动脉高压及血气的影响[J].重庆医科大学学报,2003(02):222-224. DOI： 10.13406/j.cnki.cyxb.2003.02.033.

JIANG Yingjiu, et al. Effects of urapidil on pulmonary hypertension and blood gas in rheumatic heart disease. [J]. Journal of Chongqing Medical University (2):222-224(2003) DOI： 10.13406/j.cnki.cyxb.2003.02.033.

摘要

目的 :观察乌拉地尔对合并有肺动脉高压的风心病病人右心血流动力学及动脉血气的影响。方法 :以风心病继发肺动脉高压的 34例病人为研究对象

观察静脉注射 0 .4mg/kg乌拉地尔前、后 10min、4 0min、6 0min右心血流动力学参数、体循环血压及动脉血气的变化。结果 :乌拉地尔能显著降低风心病病人的肺动脉压、肺循环阻力、肺毛细血管楔嵌压及体循环血压

但对肺循环的影响要明显强于体循环

并几乎不引起心率、心输出量及动脉血气的改变。无严重副反应发生。结论 :乌拉地尔治疗术前风心病肺动脉高压可能有很好的临床效果。

Abstract

Objective: To investigate the hemodynamic effects of right heart and changes of blood gas in rheumatic heart disease with pulmonary hypertension by urapidil. Methods: 34 patients suffering from varying degrees of pulmonary hypertension due to rheumatic heart disease were included in the study.Each patient received 0.4mg/kg urapidil by intravenous injection.In all patients

the hemodynamic record and blood gas test were performed before and 10

60 minutes after urapidil injection. Results: Pulmonary arterial pressure?pulmonary vascular resistance

pulmonary capillary wedge pressure and systemic arterial pressure were decreased after urapidil injection.The reduction of resistance in the pulmonary vascular bed was greater than that of systemic circulation.There were no significant alterations in heart rate

cardiac output and arterial blood gas.No serious side-effects were observed in the study. Conclusion:Urapidil may be a promising drug in the treatment of patients with pulmonary hypertension due to rheumatic heart disease.

关键词

乌拉地尔肺动脉高压风湿性心脏病血气

Keywords

Urapidilpulmonary hypertensionrheumatic heart diseaseBlood gas

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

The perioperative application of prostaglandin E₁ for patients with rheumatic heart diease associated with pulmonary hypertension

Research advances in the therapeutic effect of mesenchymal stem cell exosomes on pulmonary hypertension

Effects of sodium nitrite on rats with high pulmonary blood flow and pulmonary hypertension and its mechanism

Accuracy of pulmonary artery systolic pressure estimated by transthoracic echocardiography

Effect of preservation of the subvalvular apparatus on cardiac function in mitral valve replacement

Related Author

黄阳礼

蒋迎久

向小勇

李朝先

LI Xiaoconget al

Zhang Qingqing

Ma Lan

Ge Rili

Related Institution

Department of Thoracic and Cardiac Surgery, College of Clinical Medicine, Chongqing Medical University

Research Center for High Altitude Medicine， Qinghai University；Key Laboratory of High Altitude Medicine， Ministry of Education；Key Laboratory of Application and Foundation for High Altitude Medicine Research in Qinghai Province

Department of Anesthesiology,The First Affiliated Hospital of Chongqing Medical University

Department of Anesthesiology,the Children’s Hospital,Chongqing Medical University

Department of Cardiology，The First Affiliated Hospital of Chongqing Medical University

⁰